Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
RHYTHM PHARMACEUTICALS, INC. reports $52.2 million Q1 loss
By USInMinutes - May 02, 2023, 10:26 AM ET
Last Updated - Jul 18, 2023, 03:45 PM EDT
The company generated $11.50 million in quarterly revenue
RHYTHM PHARMACEUTICALS, INC. [RYTM] has reported fiscal Q1 loss of $52.20 million.
On a per-share basis, the DE based company said its diluted earnings are $0.92.
The Pharmaceutical Preparations firm posted revenue of $11.50 million in this period.
Also Read:
- Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Germany for ...
- Rhythm Pharmaceuticals to Present at 22nd Annual Needham Virtual Healthcare Conference
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants
- Rhythm Pharmaceuticals Announces New Employment Inducement Grants
- Rhythm Pharmaceuticals Announces Acquisition of Xinvento B.V. and Portfolio of Investigational ...
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News